78 related articles for article (PubMed ID: 24436316)
1. The non-linear threshold association between aspirin use and esophageal adenocarcinoma: results of a dose-response meta-analysis.
Xiaohua Y; Zhenjiang Y; Weidong L; Pengcheng X; Sidong C
Pharmacoepidemiol Drug Saf; 2014 Mar; 23(3):278-84. PubMed ID: 24436316
[TBL] [Abstract][Full Text] [Related]
2. Aspirin, nonsteroidal anti-inflammatory drugs, and the risks of cancers of the esophagus.
Sadeghi S; Bain CJ; Pandeya N; Webb PM; Green AC; Whiteman DC;
Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1169-78. PubMed ID: 18483339
[TBL] [Abstract][Full Text] [Related]
3. Frequency-risk and duration-risk relationships between aspirin use and gastric cancer: a systematic review and meta-analysis.
Ye X; Fu J; Yang Y; Gao Y; Liu L; Chen S
PLoS One; 2013; 8(7):e71522. PubMed ID: 23936269
[TBL] [Abstract][Full Text] [Related]
4. Statin use is associated with a reduction in the incidence of esophageal adenocarcinoma: a case control study.
Beales IL; Vardi I; Dearman L; Broughton T
Dis Esophagus; 2013; 26(8):838-46. PubMed ID: 22989236
[TBL] [Abstract][Full Text] [Related]
5. Regular aspirin use and esophageal cancer risk.
Jayaprakash V; Menezes RJ; Javle MM; McCann SE; Baker JA; Reid ME; Natarajan N; Moysich KB
Int J Cancer; 2006 Jul; 119(1):202-7. PubMed ID: 16450404
[TBL] [Abstract][Full Text] [Related]
6. Aspirin and non-steroidal anti-inflammatory drugs use reduce gastric cancer risk: A dose-response meta-analysis.
Huang XZ; Chen Y; Wu J; Zhang X; Wu CC; Zhang CY; Sun SS; Chen WJ
Oncotarget; 2017 Jan; 8(3):4781-4795. PubMed ID: 27902474
[TBL] [Abstract][Full Text] [Related]
7. Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis.
Corley DA; Kerlikowske K; Verma R; Buffler P
Gastroenterology; 2003 Jan; 124(1):47-56. PubMed ID: 12512029
[TBL] [Abstract][Full Text] [Related]
8. Association of regular aspirin use and breast cancer risk.
Swede H; Mirand AL; Menezes RJ; Moysich KB
Oncology; 2005; 68(1):40-7. PubMed ID: 15802928
[TBL] [Abstract][Full Text] [Related]
9. Regular statin and aspirin use in patients with Barrett's oesophagus is associated with a reduced incidence of oesophageal adenocarcinoma.
Beales IL; Vardi I; Dearman L
Eur J Gastroenterol Hepatol; 2012 Aug; 24(8):917-23. PubMed ID: 22569083
[TBL] [Abstract][Full Text] [Related]
10. Nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric adenocarcinomas in Los Angeles County.
Duan L; Wu AH; Sullivan-Halley J; Bernstein L
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):126-34. PubMed ID: 18187391
[TBL] [Abstract][Full Text] [Related]
11. Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer.
Farrow DC; Vaughan TL; Hansten PD; Stanford JL; Risch HA; Gammon MD; Chow WH; Dubrow R; Ahsan H; Mayne ST; Schoenberg JB; West AB; Rotterdam H; Fraumeni JF; Blot WJ
Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):97-102. PubMed ID: 9488582
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis on the association between nonsteroidal anti-inflammatory drug use and lung cancer risk.
Xu J; Yin Z; Gao W; Liu L; Wang R; Huang P; Yin Y; Liu P; Yu R; Shu Y
Clin Lung Cancer; 2012 Jan; 13(1):44-51. PubMed ID: 21813335
[TBL] [Abstract][Full Text] [Related]
13. Regular use of aspirin and prostate cancer risk (United States).
Menezes RJ; Swede H; Niles R; Moysich KB
Cancer Causes Control; 2006 Apr; 17(3):251-6. PubMed ID: 16489532
[TBL] [Abstract][Full Text] [Related]
14. Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence.
Anderson LA; Johnston BT; Watson RG; Murphy SJ; Ferguson HR; Comber H; McGuigan J; Reynolds JV; Murray LJ
Cancer Res; 2006 May; 66(9):4975-82. PubMed ID: 16651456
[TBL] [Abstract][Full Text] [Related]
15. Aspirin as a potential modality for the chemoprevention of breast cancer: A dose-response meta-analysis of cohort studies from 857,831 participants.
Lu L; Shi L; Zeng J; Wen Z
Oncotarget; 2017 Jun; 8(25):40389-40401. PubMed ID: 28418881
[TBL] [Abstract][Full Text] [Related]
16. Regular analgesic use and risk of multiple myeloma.
Moysich KB; Bonner MR; Beehler GP; Marshall JR; Menezes RJ; Baker JA; Weiss JR; Chanan-Khan A
Leuk Res; 2007 Apr; 31(4):547-51. PubMed ID: 16962170
[TBL] [Abstract][Full Text] [Related]
17. A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence.
Jacobs EJ; Rodriguez C; Mondul AM; Connell CJ; Henley SJ; Calle EE; Thun MJ
J Natl Cancer Inst; 2005 Jul; 97(13):975-80. PubMed ID: 15998950
[TBL] [Abstract][Full Text] [Related]
18. Role of aspirin in chemoprevention of esophageal adenocarcinoma: a meta-analysis.
Sivarasan N; Smith G
J Dig Dis; 2013 May; 14(5):222-30. PubMed ID: 23421723
[TBL] [Abstract][Full Text] [Related]
19. Low-Dose Aspirin Use Does Not Increase Survival in 2 Independent Population-Based Cohorts of Patients With Esophageal or Gastric Cancer.
Spence AD; Busby J; Johnston BT; Baron JA; Hughes CM; Coleman HG; Cardwell CR
Gastroenterology; 2018 Mar; 154(4):849-860.e1. PubMed ID: 29122547
[TBL] [Abstract][Full Text] [Related]
20. Low-dose aspirin and cancer mortality: a meta-analysis of randomized trials.
Mills EJ; Wu P; Alberton M; Kanters S; Lanas A; Lester R
Am J Med; 2012 Jun; 125(6):560-7. PubMed ID: 22513195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
